Evidence map›Paper›PMID 35026030›Full record

ArticleJournal of the National Cancer Institute2022

Risk Stratification for Early-Onset Colorectal Cancer Using a Combination of Genetic and Environmental Risk Scores: An International Multi-Center Study.

Alexi N Archambault, Jihyoun Jeon, Yi Lin, Minta Thomas, Tabitha A Harrison, D Timothy Bishop, Hermann Brenner, Graham Casey, Andrew T Chan, Jenny Chang-Claude and 34 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of the National Cancer Institute, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2023
    Guideline
  2. Association ofGenetics research · 2022
    Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Associations Between Prescreening Dietary Patterns and Longitudinal Colonoscopy Outcomes in Veterans.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Biological Age Acceleration and Colonic Polyps in Persons under Age 50.Cancer prevention research (Philadelphia, Pa.) · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 9 countries.

Alexi N ArchambaultDivision of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY, USA.ORCID 0000-0002-5397-8163
Jihyoun JeonDepartment of Epidemiology, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0001-7003-3412
Yi LinPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Minta ThomasPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Tabitha A HarrisonPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID 0000-0002-4173-7530
D Timothy BishopLeeds Institute of Medical Research, St. James's University of Leeds, Leeds, UK.ORCID 0000-0002-8752-8785
Hermann BrennerDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-6129-1572
Graham CaseyCenter for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.
Andrew T ChanDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0001-7284-6767
Jenny Chang-ClaudeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0001-8919-1971
Jane C FigueiredoDepartment of Medicine, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.ORCID 0000-0002-2452-3194
Steven GallingerLunenfeld Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, ON, Canada.
Stephen B GruberCenter for Precision Medicine, City of Hope National Medical Center, Duarte, CA, USA.ORCID 0000-0001-8656-7822
Marc J GunterNutrition and Metabolism Section, International Agency for Research on Cancer, World Health Organization, Lyon, France.ORCID 0000-0001-5472-6761
Feng GuoDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-5026-7024
Michael HoffmeisterDivision of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.ORCID 0000-0002-8307-3197
Mark A JenkinsCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-8964-6160
Temitope O KekuCenter for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA.
Loïc Le MarchandEpidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.ORCID 0000-0001-5013-980X
Li LiDepartment of Family Medicine, University of Virginia, Charlottesville, VA, USA.
Victor MorenoOncology Data Analytics Program, Catalan Institute of Oncology-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.ORCID 0000-0002-2818-5487
Polly A NewcombPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Rish PaiDepartment of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Scottsdale, AZ, USA.ORCID 0000-0002-2692-221X
Patrick S ParfreyFaculty of Medicine, Memorial University, St John's, NL, Canada.
Gad RennertDepartment of Community Medicine and Epidemiology, Lady Davis Carmel Medical Center, Haifa, Israel.ORCID 0000-0002-8512-068X
Lori C SakodaPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.ORCID 0000-0002-0900-5735
Jeffrey K LeeDivision of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Martha L SlatteryDepartment of Internal Medicine, University of Utah, Salt Lake City, UT, USA.
Mingyang SongDivision of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-1324-0316
Aung Ko WinCentre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.ORCID 0000-0002-2794-5261
Michael O WoodsDiscipline of Genetics, Memorial University of Newfoundland, St John's, NL, Canada.ORCID 0000-0001-8180-418X
Neil MurphySection of Nutrition and Metabolism, International Agency for Research on Cancer, Lyon, France.ORCID 0000-0003-3347-8249
Peter T CampbellDepartment of Population Science, American Cancer Society, Atlanta, GA, USA.ORCID 0000-0002-5549-2036
Yu-Ru SuBiostatistics Unit, Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
Iris Lansdorp-VogelaarDepartment of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.
Elisabeth F P PeterseDepartment of Public Health, Erasmus University Medical Center, Rotterdam, the Netherlands.ORCID 0000-0002-4249-6169
Yin CaoDivision of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St Louis, MO, USA.ORCID 0000-0001-9835-7662
Anne Zeleniuch-JacquotteDivision of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY, USA.
Peter S LiangDepartment of Medicine, New York University School of Medicine, New York, NY, USA.ORCID 0000-0002-4160-421X
Mengmeng DuDepartment of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Douglas A CorleyDivision of Research, Kaiser Permanente Northern California, Oakland, CA, USA.
Li HsuPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Ulrike PetersPublic Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Richard B HayesDivision of Epidemiology, Department of Population Health, New York University School of Medicine, New York, NY, USA.ORCID 0000-0002-0918-661X
New York University · USFred Hutch Cancer Center · USGerman Cancer Research Center · DEKaiser Permanente · USUniversity of Washington · USCentre international de recherche sur le cancer · FRErasmus MC · NLMemorial University of Newfoundland · CAThe University of Melbourne · AUUniversity of Virginia · USAmerican Cancer Society · USBroad Institute · USCity Of Hope National Medical Center · USHarvard University · USInstitut d'Investigació Biomédica de Bellvitge · ESKaiser Permanente Washington Health Research Institute · USMayo Clinic in Arizona · USMemorial Sloan Kettering Cancer Center · USMount Sinai Hospital · CATechnion – Israel Institute of Technology · IL

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Tissue and Pathology ResourcesP50CA127003 · NCI · DANA-FARBER CANCER INST · PI BASS, ADAM JOEL · 2007 to 2023
$33.2M
Data sharing: the Colon Cancer Family Registry CohortU01CA167551 · NCI · UNIVERSITY OF MELBOURNE · PI Daniel David BUCHANAN, Steven Gallinger · 2018 to 2026
$16.8M
Using Functional Genomics to Inform Gene Environment Interactions for Colorectal CancerR01CA201407 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CASEY, GRAHAM, GAUDERMAN, WILLIAM JAMES · 2016 to 2020
$9.6M
NYU Training Program in Healthcare Delivery Science and Population Health ResearchT32HS026120 · AHRQ · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI HORWITZ, LEORA, SCHWARTZ, MARK D · 2018 to 2023
$3.4M
Comprehensive Colorectal Cancer Risk Prediction to Inform Personalized ScreeningR01CA206279 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI CORLEY, DOUGLAS ALLEN, HAYES, RICHARD BERNARD · 2017 to 2020
$2.7M
AHRQ HHS T32 HS026120Cancer Research UK 19167NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA015704NCI NIH HHS P50 CA127003NCI NIH HHS R01 CA201407NCI NIH HHS R01 CA206279NCI NIH HHS R03CA21577502World Health Organization 001
6 · The paper itself

Abstract

backgroundThe incidence of colorectal cancer (CRC) among individuals aged younger than 50 years has been increasing. As screening guidelines lower the recommended age of screening initiation, concerns including the burden on screening capacity and costs have been recognized, suggesting that an individualized approach may be warranted. We developed risk prediction models for early-onset CRC that incorporate an environmental risk score (ERS), including 16 lifestyle and environmental factors, and a polygenic risk score (PRS) of 141 variants.

methodsRelying on risk score weights for ERS and PRS derived from studies of CRC at all ages, we evaluated risks for early-onset CRC in 3486 cases and 3890 controls aged younger than 50 years. Relative and absolute risks for early-onset CRC were assessed according to values of the ERS and PRS. The discriminatory performance of these scores was estimated using the covariate-adjusted area under the receiver operating characteristic curve.

resultsIncreasing values of ERS and PRS were associated with increasing relative risks for early-onset CRC (odds ratio per SD of ERS = 1.14, 95% confidence interval [CI] = 1.08 to 1.20; odds ratio per SD of PRS = 1.59, 95% CI = 1.51 to 1.68), both contributing to case-control discrimination (area under the curve = 0.631, 95% CI = 0.615 to 0.647). Based on absolute risks, we can expect 26 excess cases per 10 000 men and 21 per 10 000 women among those scoring at the 90th percentile for both risk scores.

conclusionsPersonal risk scores have the potential to identify individuals at differential relative and absolute risk for early-onset CRC. Improved discrimination may aid in targeted CRC screening of younger, high-risk individuals, potentially improving outcomes.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerAgedFemaleGenetic Predisposition to DiseaseHumansMaleMass ScreeningMiddle AgedRisk AssessmentRisk Factors

Identifiers

PMID35026030
PMCPMC9002285
OpenAlexW4206450812

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.